Home / David L. Joffe, BSPharm, CDE, FACA (page 3)

David L. Joffe, BSPharm, CDE, FACA

(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

April 6, 2019

This week two of our most favored medical professionals chime in on the effects of using medications. Our exercise guru Dr. Sheri Colberg has an interesting feature on how non-diabetes medication can affect exercise and diabetes, and our Medical Editor Joy Pape shares information on the idea of giving Metformin …

Read More »

April 2, 2019

This week our medical editor, Joy Pape, was faced with patient questions on the contaminated ARB’s, that many of you have also gotten. She had been on the front side of the valsartan problem and was changing her patients to losartan, only to have to call them back. Check out …

Read More »

March 30, 2019

In the last couple of weeks I have been bombarded by ads from CE companies on weight loss programs. Intermittent fasting, keto, low fat, high fat, low carb, low calorie and more. Seems like every “expert” has positive proof that their method works. And you know what, they are all …

Read More »

March 26, 2019

Sometimes our obsession with clinically proven data can get in the way of patient care. We can see that this week in an article about the official indication for the dual SGLT-1/2 inhibitor sotagliflozin. To find out what our patients may end up missing, check out our article #2. Dave …

Read More »

March 23, 2019

This week we focus on cardiovascular health in two of our articles. Our two interns, Dahlia Elimairi and Ghazal Blair, wanted to focus on cardiovascular health because for so many of our patients this will be their most important focus to living a long life. We look at how large …

Read More »

March 19, 2019

Whether you believe in global warming or not one thing is for sure: fungi, bacteria and viruses that were frozen in the Ice Age are starting to thaw out at both of the polar ice caps and previously tundra areas. The question is, are they still active, will they come …

Read More »

March 16, 2019

Metformin was approved in Canada in 1972, but did not receive approval by the FDA for type 2 diabetes until 1994, this because its sister drug phenformin happened to kill people. Although it took us 22 years to get approval we have certainly used enough in the past 25 years to make up for it. …

Read More »

March 12, 2019

Years ago, we only had a couple of drugs for diabetes and we wanted more. Then, in the past 10 years, we have had an explosion of drugs and you can bet there are more coming soon. This week, Joy Pape sits down with Jeffery Emmick from Eli Lilly to …

Read More »

March 9, 2019

Thanks to everyone who asked for more information on the “sartan” contamination recall. Some of you asked how this happened, a few wanted to know the science behind it, and almost everybody wanted to know how the pharmaceutical industry and the FDA were going to fix it. With those comments …

Read More »

March 5, 2019

Last week, we had some information on the Da Qing Diabetes study, and I mentioned the problem with availability of the most popular ARB’s. Many of you asked for more information and we are completing a special report on what is going on and some possible solutions. Look to our …

Read More »